Bill Text: CA SB115 | 2013-2014 | Regular Session | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Public Utilities Commission: Bagley-Keene Open Meeting

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Engrossed - Dead) 2014-08-22 - Read third time and amended. (Page 6341.) Ordered to third reading. Re-referred to Com. on RLS. pursuant to Assembly Rule 97. [SB115 Detail]

Download: California-2013-SB115-Introduced.html
BILL NUMBER: SB 115	INTRODUCED
	BILL TEXT


INTRODUCED BY   Senator Hill

                        JANUARY 16, 2013

   An act to amend Section 125290.40 of the Health and Safety Code,
relating to stem cell research.


	LEGISLATIVE COUNSEL'S DIGEST


   SB 115, as introduced, Hill. Stem cell research: Independent
Citizen's Oversight Committee.
   The California Stem Cell Research and Cures Act, an initiative
measure approved by the voters at the November 2, 2004, statewide
general election as Proposition 71, establishes the California
Institute for Regenerative Medicine, the purpose of which is, among
other things, to make grants and loans for stem cell research.
Existing law establishes the Independent Citizen's Oversight
Committee (ICOC), which is required to perform various functions and
duties with regard to the operation of the institute. Existing law
authorizes the ICOC to annually modify its funding and finance
programs to optimize the institute's ability to achieve the objective
that its activities be revenue-positive for the state during its
first 5 years of operation without jeopardizing the progress of its
core medical and scientific research program.
   This bill would make a nonsubstantive change to that provision.
   Vote: majority. Appropriation: no. Fiscal committee: no.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Section 125290.40 of the Health and Safety Code is
amended to read:
   125290.40.  ICOC Functions
   The ICOC shall perform the following functions:
   (a) Oversee the operations of the institute.
   (b) Develop annual and long-term strategic research and financial
plans for the institute.
   (c) Make final decisions on research standards and grant awards in
California.
   (d) Ensure the completion of an annual financial audit of the
institute's operations.
   (e) Issue public reports on the activities of the institute.
   (f) Establish policies regarding intellectual property rights
arising from research funded by the institute.
   (g) Establish rules and guidelines for the operation of the ICOC
and its working groups.
   (h) Perform all other acts necessary or appropriate in the
exercise of its power, authority, and jurisdiction over the
institute.
   (i) Select members of the working groups.
   (j) Adopt, amend, and rescind rules and regulations to carry out
the purposes and provisions of this chapter, and to govern the
procedures of the ICOC. Except as provided in subdivision (k), these
rules and regulations shall be adopted in accordance with the
Administrative Procedure Act (Government Code, Title 2, Division 3,
Part 1, Chapter 4.5, Sections 11371 et seq.).
   (k) Notwithstanding the Administrative Procedure Act (APA), and in
order to facilitate the immediate commencement of research covered
by this chapter, the ICOC may adopt interim regulations without
compliance with the procedures set forth in the APA. The interim
regulations shall remain in effect for 270 days unless earlier
superseded by regulations adopted pursuant to the APA.
   (l) Request the issuance of bonds from the California Stem Cell
Research and Cures Finance Committee and loans from the Pooled Money
Investment Board.
   (m) May annually modify its funding and finance programs to
optimize the institute's ability to achieve the objective that its
activities be revenue-positive for the  State of California
  state  during its first five years of operation
without jeopardizing the progress of its core medical and scientific
research program.
   (n) Notwithstanding Section 11005 of the Government Code, accept
additional revenue and real and personal property, including, but not
limited to, gifts, royalties, interest, and appropriations that may
be used to supplement annual research grant funding and the
operations of the institute.
   (o) Under the guidance of the ICOC, the institute shall create a
succession plan addressing changes in leadership of both the
institute and the ICOC designed to minimize disruption and adverse
impacts to the activities of the institute. A copy of the succession
plan shall be transmitted to the Governor, Controller, and the
Legislature within 30 days of its completion. The succession plan
should include, but is not limited to:
   (1) An assessment of leadership needs before beginning a search.
   (2) An outline of succession procedures.
   (3) Strategies to ensure successful knowledge transfer.
                    
feedback